Targeting a bacterial stress response to enhance antibiotic action
暂无分享,去创建一个
Pradeep K. Singh | C. Manoil | Y. Kaneko | A. Hinz | Colin Manoil | Aaron Hinz | A. Angermeyer | Yukihiro Kaneko | Samuel Lee | Elizabeth Bauerle | Angus Angermeyer | Katy Juhaszova | Samuel A. Lee | Elizabeth Bauerle | Katy Juhaszova
[1] B. D. Davis. Mechanism of bactericidal action of aminoglycosides , 1987, Microbiological reviews.
[2] H. Yoneyama,et al. Assignment of the Substrate-Selective Subunits of the MexEF-OprN Multidrug Efflux Pump of Pseudomonas aeruginosa , 2000, Antimicrobial Agents and Chemotherapy.
[3] K. Poole,et al. Antibiotic Inducibility of the MexXY Multidrug Efflux System of Pseudomonas aeruginosa: Involvement of the Antibiotic-Inducible PA5471 Gene Product , 2006, Journal of bacteriology.
[4] E. Greenberg,et al. Identification, Timing, and Signal Specificity of Pseudomonas aeruginosa Quorum-Controlled Genes: a Transcriptome Analysis , 2003, Journal of bacteriology.
[5] B. D. Davis,et al. Misread protein creates membrane channels: an essential step in the bactericidal action of aminoglycosides. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[6] E. Bakker,et al. The bactericidal action of streptomycin: membrane permeabilization caused by the insertion of mistranslated proteins into the cytoplasmic membrane of Escherichia coli and subsequent caging of the antibiotic inside the cells due to degradation of these proteins. , 1992, Journal of general microbiology.
[7] R. Hancock,et al. Novel Genetic Determinants of Low-Level Aminoglycoside Resistance in Pseudomonas aeruginosa , 2008, Antimicrobial Agents and Chemotherapy.
[8] C. Goss,et al. Incidence and risk factors for multiple antibiotic-resistant Pseudomonas aeruginosa in cystic fibrosis. , 2005, Chest.
[9] P. Bradford,et al. Late stage antibacterial drugs in the clinical pipeline. , 2007, Current opinion in microbiology.
[10] R. Monaghan,et al. Antibacterial drug discovery--then, now and the genomics future. , 2006, Biochemical pharmacology.
[11] A. Prince. Biofilms, antimicrobial resistance, and airway infection. , 2002, The New England journal of medicine.
[12] T. Raivio,et al. Characterization of the Cpx Regulon in Escherichia coli Strain MC4100 , 2008, Journal of bacteriology.
[13] P. Lejeune,et al. The Cpx system of Escherichia coli, a strategic signaling pathway for confronting adverse conditions and for settling biofilm communities? , 2006, Research in microbiology.
[14] Takeshi Mizuno,et al. Transcriptome analysis of all two‐component regulatory system mutants of Escherichia coli K‐12 , 2002, Molecular microbiology.
[15] R. Gibson,et al. Pathophysiology and management of pulmonary infections in cystic fibrosis. , 2003, American journal of respiratory and critical care medicine.
[16] Roger Finch,et al. Lack of development of new antimicrobial drugs: a potential serious threat to public health. , 2005, The Lancet. Infectious diseases.
[17] J. Wierzbowski,et al. Combination drugs, an emerging option for antibacterial therapy. , 2007, Trends in biotechnology.
[18] D. Bumann. Has nature already identified all useful antibacterial targets? , 2008, Current opinion in microbiology.
[19] Eric Haugen,et al. Comprehensive transposon mutant library of Pseudomonas aeruginosa , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[20] Pradeep K. Singh,et al. The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity. , 2007, The Journal of clinical investigation.
[21] A. Ishihama,et al. Characterization of Copper-Inducible Promoters Regulated by CpxA/CpxR in Escherichia coli , 2006, Bioscience, biotechnology, and biochemistry.
[22] Jeffrey H. Miller,et al. Determination of Antibiotic Hypersensitivity among 4,000 Single-Gene-Knockout Mutants of Escherichia coli , 2008, Journal of bacteriology.
[23] H. Schweizer. Alielic exchange in Pseudomonas aeruginosa using novel ColE1‐type vectors and a family of cassettes containing a portable oriT and the counter‐selectable Bacillus subtilis sacB marker , 1992, Molecular microbiology.
[24] J. Collins,et al. A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics , 2007, Cell.
[25] J. Karlowsky,et al. Factors Associated with Relative Rates of Antibiotic Resistance in Pseudomonas aeruginosa Isolates Tested in Clinical Laboratories in the United States from 1999 to 2002 , 2004, Antimicrobial Agents and Chemotherapy.
[26] Philip S. Stewart,et al. Contributions of Antibiotic Penetration, Oxygen Limitation, and Low Metabolic Activity to Tolerance of Pseudomonas aeruginosa Biofilms to Ciprofloxacin and Tobramycin , 2003, Antimicrobial Agents and Chemotherapy.
[27] G. Storz,et al. Repression of small toxic protein synthesis by the Sib and OhsC small RNAs , 2008, Molecular microbiology.
[28] T. Silhavy,et al. Quality control in the bacterial periplasm. , 2004, Biochimica et biophysica acta.
[29] K. Bostian,et al. Practical applications and feasibility of efflux pump inhibitors in the clinic--a vision for applied use. , 2006, Biochemical pharmacology.
[30] J. Collins,et al. Mistranslation of Membrane Proteins and Two-Component System Activation Trigger Antibiotic-Mediated Cell Death , 2008, Cell.
[31] H. Schweizer,et al. A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. , 1998, Gene.
[32] T. Silhavy,et al. CpxP, a Stress-Combative Member of the Cpx Regulon , 1998, Journal of bacteriology.
[33] Michelle D. Brazas,et al. Using microarray gene signatures to elucidate mechanisms of antibiotic action and resistance. , 2005, Drug discovery today.
[34] R. Utsumi,et al. Inhibitors targeting two-component signal transduction. , 2008, Advances in experimental medicine and biology.
[35] A. Kihara,et al. Different pathways for protein degradation by the FtsH/HflKC membrane-embedded protease complex: an implication from the interference by a mutant form of a new substrate protein, YccA. , 1998, Journal of molecular biology.
[36] D. Paterson,et al. High Prevalence of Metallo-β-Lactamase and 16S rRNA Methylase Coproduction among Imipenem-Resistant Pseudomonas aeruginosa Isolates in Brazil , 2007, Antimicrobial Agents and Chemotherapy.
[37] H. K. Bourns. Management of Sepsis , 1960, The Medical journal of the South-West.
[38] A. McGuire,et al. Genome-wide Profiling of Promoter Recognition by the Two-component Response Regulator CpxR-P in Escherichia coli * , 2002, The Journal of Biological Chemistry.
[39] David A. D'Argenio,et al. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[40] M. Parsek,et al. Bacterial biofilms: an emerging link to disease pathogenesis. , 2003, Annual review of microbiology.
[41] Koreaki Ito,et al. Cellular functions, mechanism of action, and regulation of FtsH protease. , 2005, Annual review of microbiology.
[42] L. Silver. Multi-targeting by monotherapeutic antibacterials , 2007, Nature Reviews Drug Discovery.
[43] T. Dougherty,et al. Genomics-Based Approaches to Novel Antimicrobial Target Discovery , 2003 .
[44] Koreaki Ito,et al. The Cpx stress response system of Escherichia coli senses plasma membrane proteins and controls HtpX, a membrane protease with a cytosolic active site , 2002, Genes to cells : devoted to molecular & cellular mechanisms.
[45] B. Wanner,et al. Phenotype MicroArray Analysis of Escherichia coli K-12 Mutants with Deletions of All Two-Component Systems , 2003, Journal of bacteriology.
[46] N. Gotoh,et al. Characterization of MexE–MexF–OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa , 1997, Molecular microbiology.
[47] Marina S. Kuznetsova,et al. Functions Required for Extracellular Quinolone Signaling by Pseudomonas aeruginosa , 2002, Journal of bacteriology.
[48] J. Davies,et al. The world of subinhibitory antibiotic concentrations. , 2006, Current opinion in microbiology.
[49] K. Poole. Aminoglycoside Resistance in Pseudomonas aeruginosa , 2005, Antimicrobial Agents and Chemotherapy.
[50] T. Silhavy,et al. Sensing external stress: watchdogs of the Escherichia coli cell envelope. , 2005, Current opinion in microbiology.
[51] C. Manoil,et al. lac permease of Escherichia coli: topology and sequence elements promoting membrane insertion. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[52] D. Pompliano,et al. Drugs for bad bugs: confronting the challenges of antibacterial discovery , 2007, Nature Reviews Drug Discovery.
[53] Kim D Janda,et al. Histidine kinases as targets for new antimicrobial agents. , 2002, Bioorganic & medicinal chemistry.
[54] Robert E. W. Hancock,et al. Complex Ciprofloxacin Resistome Revealed by Screening a Pseudomonas aeruginosa Mutant Library for Altered Susceptibility , 2008, Antimicrobial Agents and Chemotherapy.
[55] Fernando Baquero,et al. The Neglected Intrinsic Resistome of Bacterial Pathogens , 2008, PloS one.